Subscribe to Our Free Newsletter
 


HOME
LOGIN
SUBSCRIBE

Timing Strategies

Subscriber's Q & A
Pro Timer Strategy
Conservative Strategies
SmallCap Fund Timer
Bond Fund Timer
Gold Fund Timer
Sector Fund Timer
U.S. Dollar Fund Timer
ETF & Stock Timer
Stock Market Timing
Testimonials

Subscriber Reports
WEEKLY COMMENTS
Editor 's Report
ACTIVE STRATEGIES
Sector Fund Timer
SmallCap Timer
Gold Timer
CONSERVATIVE
Conserv. S&P Timer
International Fund Timer
Conserv. REIT Timer
Diversified Timing Port.
AGGRESSIVE
S&P OTC Pro Timer
ETF Timer
Bond Timer
U.S. Dollar Fund Timer
Stock Timer

About Us
Subscriber Support
Email Policy
Terms of Use
Privacy Policy
Prior Commentaries
Press Releases
Editor's Blog
Site Map

Subscriptions
Free Two Week Trial
Free Timing Newsletter
Financial Links
Add Your Link

 

  • Press Releases From The FibTimer Stock Market Timing Services    


Big Rally in Shares of Biotech HOLDRS (AMEX: BBH) Says Market Timer Frank Kollar

January 20, 2010 (FinancialWire) (By Frank Kollar)

Shares of the Biotech HOLDRS (AMEX: BBH) have begun the final run back to their prior July highs.

Biotech HOLDRS had greater losses than the major indexes in the late October sell off, losing 14.3% from their July highs after they had almost reached $105 a share.

They had since rallied back to strong resistance at $98.76 in mid-November, the 61.8% retracement level for the July to October decline, before stalling at that level and again pulling back.

But the rally picked up steam again in January and this time closed above the $98.76 level, thus forecasting a run for the July highs.

After losing ground last Friday, January 15, before the three day holiday weekend, Biotech HOLDRS gapped open on Tuesday, January 19 and never looked back, tacking on some 2% and closing at $101.42.

Biotech HOLDRS should close in on the $105 level in coming days and that will be the make or break point for the rally. A decisive close above and Biotech HOLDRS could realize substantial additional gains in coming weeks.

The Fibtimer.com (http://www.fibtimer.com) ETF Timing Strategy holds a position in Biotech HOLDRS.

Kollar is editor and chief analyst at FibTimer.com (http://www.fibtimer.com) which offers market timing strategies for S&P and Nasdaq index fund traders, as well as bond, gold, small cap, sector, ETF and stock trading strategies.

Kollar’s research has shown that the financial markets are in tradable trends approximately 80 percent of the time. FibTimer strategies define trends and trade them in both advancing and declining markets. Caring nothing about what newscasters say or what the latest economic indicator predicts, trends are where the profits are, and that is where FibTimer is.

Go to previous Press Releases & Trading Notes.


Note: These Press Releases are short term in nature. They may or may not reflect the same position as current subscriber reports which typically have longer time frames.

© Copyright 1996-2010, Market Timing Strategies, Inc., All Rights Reserved.     

FibTimer reports may not be redistributed without permission. These Trading Notes however may be distributed without permission.

Disclaimer: The financial markets are risky. Investing is risky. Past performance does not guarantee future performance. The foregoing has been prepared solely for informational purposes and is not a solicitation, or an offer to buy or sell any security. Opinions are based on historical research and data believed reliable, but there is no guarantee that future results will be profitable.


Top of the page

 

© Copyright 1996-2010 Kollar Market Analytics Inc All Rights Reserved

Design by LightMix